Marksans Pharma submits disclosures of related party transactions

26 Nov 2019 Evaluate

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed about submission of disclosures of related party transactions for the half year ended 30th September, 2019. The financial results for the quarter and half year ended 30th September, 2019 both standalone and consolidated were published on 12th November, 2019. 

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×